Vitrolife AB Statistics
Total Valuation
Vitrolife AB has a market cap or net worth of 1.30 billion. The enterprise value is 1.39 billion.
| Market Cap | 1.30B |
| Enterprise Value | 1.39B |
Important Dates
The last earnings date was Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | May 2, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.07% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 63.74% |
| Float | 75.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 18.83 |
| PS Ratio | 3.50 |
| PB Ratio | 1.52 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 32.95 |
| P/OCF Ratio | 18.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.07, with an EV/FCF ratio of 35.21.
| EV / Earnings | -2.56 |
| EV / Sales | 3.61 |
| EV / EBITDA | 13.07 |
| EV / EBIT | n/a |
| EV / FCF | 35.21 |
Financial Position
The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.20.
| Current Ratio | 3.40 |
| Quick Ratio | 2.61 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 1.69 |
| Debt / FCF | 4.40 |
| Interest Coverage | -94.80 |
Financial Efficiency
Return on equity (ROE) is -46.55% and return on invested capital (ROIC) is -42.26%.
| Return on Equity (ROE) | -46.55% |
| Return on Assets (ROA) | -21.15% |
| Return on Invested Capital (ROIC) | -42.26% |
| Return on Capital Employed (ROCE) | -46.01% |
| Weighted Average Cost of Capital (WACC) | 14.03% |
| Revenue Per Employee | 324,251 |
| Profits Per Employee | -472,427 |
| Employee Count | 1,151 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 3.46 |
Taxes
In the past 12 months, Vitrolife AB has paid 13.78 million in taxes.
| Income Tax | 13.78M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.22% in the last 52 weeks. The beta is 2.06, so Vitrolife AB's price volatility has been higher than the market average.
| Beta (5Y) | 2.06 |
| 52-Week Price Change | -47.22% |
| 50-Day Moving Average | 18.79 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 35.16 |
| Average Volume (20 Days) | 1,071 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitrolife AB had revenue of 373.21 million and -543.76 million in losses. Loss per share was -4.02.
| Revenue | 373.21M |
| Gross Profit | 216.66M |
| Operating Income | -524.56M |
| Pretax Income | -529.98M |
| Net Income | -543.76M |
| EBITDA | 102.96M |
| EBIT | -524.56M |
| Loss Per Share | -4.02 |
Balance Sheet
The company has 87.77 million in cash and 174.13 million in debt, with a net cash position of -86.36 million.
| Cash & Cash Equivalents | 87.77M |
| Total Debt | 174.13M |
| Net Cash | -86.36M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 856.55M |
| Book Value Per Share | 6.32 |
| Working Capital | 160.24M |
Cash Flow
In the last 12 months, operating cash flow was 68.89 million and capital expenditures -29.29 million, giving a free cash flow of 39.60 million.
| Operating Cash Flow | 68.89M |
| Capital Expenditures | -29.29M |
| Free Cash Flow | 39.60M |
| FCF Per Share | n/a |
Margins
Gross margin is 58.05%, with operating and profit margins of -140.55% and -145.70%.
| Gross Margin | 58.05% |
| Operating Margin | -140.55% |
| Pretax Margin | -142.01% |
| Profit Margin | -145.70% |
| EBITDA Margin | 27.59% |
| EBIT Margin | -140.55% |
| FCF Margin | 10.61% |
Dividends & Yields
This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 0.67%.
| Dividend Per Share | 0.07 |
| Dividend Yield | 0.67% |
| Dividend Growth (YoY) | 25.81% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | 0.07% |
| Shareholder Yield | 0.74% |
| Earnings Yield | -41.68% |
| FCF Yield | 3.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 1, 2018. It was a forward split with a ratio of 1.25.
| Last Split Date | Jun 1, 2018 |
| Split Type | Forward |
| Split Ratio | 1.25 |
Scores
Vitrolife AB has an Altman Z-Score of 2.13 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.13 |
| Piotroski F-Score | 5 |